Place it in its market
Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.
See how Context works →On the price, the facts of the public record■Insider buy□Insider sell
With an account, also○dividends▲splits◌next earningswith an account
End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.
Latest on record
The most recent facts, as filed.
Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.
- Oct 13, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
- Sep 29, 2026Reported sale · Form 4Alan B. Sandler, Chief Development Officer · $441.8KOpen the filing ↗
- Sep 29, 2026Reported sale · Form 4Alan B. Sandler, Chief Development Officer · $324.6KOpen the filing ↗
In numbers
What this profile holds, counted.
Closes · 1 year250
SEC filings on record82423 flagged findings
Reported transactions (Form 4)80since Jan 7, 2026 · and 15 other holdings
Corporate events (8-K)25since Mar 20, 2020
What the record says
Description, identity and filings, each with its source.
Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.
Regulatory history
Topics detected in its SEC reports, with the original excerpt.
Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.
- 2026-04-17share offering or dilution eventrecentOpen filing ↗“…has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided…”
+1 more passage from the same document
- “…to be complete and is qualified in its entirety by reference to such exhibit. Item 9.01 Financial Statements and Exhibits. (d)…”
- 2026-04-17capital return (buybacks/dividends)recentOpen filing ↗“…rate applicable to the conversion of that Note will be increased in certain circumstances if it is converted after it is…”
+1 more passage from the same document
- “…of that Note will be increased in certain circumstances if it is converted after it is called for redemption. If certain…”
- 2026-04-16share offering or dilution eventrecentOpen filing ↗“…by reference. The foregoing description of the Equity Underwriting Agreement does not purport to be complete and is qualified in…”
+1 more passage from the same document
- “…with the Equity Offering, on April 14, 2026, the Company entered into a separate underwriting agreement with J.P. Morgan…”
- 2026-04-15share offering or dilution eventrecentOpen filing ↗“…4, 2024) 10,563,381 Shares of Common Stock Common stock Revolution Medicines, Inc. is offering shares 10,563,381 of its common…”
+1 more passage from the same document
- “…stock. Our common stock is listed on the Nasdaq Global Select Market under the symbol “RVMD.” The last reported sale price of our…”
- 2026-04-15listing compliance noticerecentOpen filing ↗“…beneficial takeover of us. Certain provisions in the convertible notes and the indenture governing the convertible notes could…”
+1 more passage from the same document
- “…may limit our ability to repurchase the convertible notes or pay cash upon their conversion. Noteholders may, subject to a…”
- 2026-04-15capital return (buybacks/dividends)recentOpen filing ↗“…indenture governing the convertible notes could make a third party attempt to acquire us more difficult or expensive. For example, if…”
+1 more passage from the same document
- “…notes. In either case, and in other cases, our obligations under the convertible notes and the indenture could increase the cost…”
- 2026-04-15share offering or dilution eventrecentOpen filing ↗“…1 d124966d424b5.htm 424B5 Filed Pursuant to Rule 424(b)(5) Registration No. 333-277640 PROSPECTUS SUPPLEMENT (To Prospectus dated…”
- 2026-04-15capital return (buybacks/dividends)recentOpen filing ↗“…which represents an initial conversion price of approximately $198.80 per share, and is subject to adjustment as described in this…”
+1 more passage from the same document
- “…to that note, in which case the conversion rate applicable to the conversion of that note will be increased in certain…”
Original excerpts from SEC filings, untranslated. Not advice and not a prediction.
The 25 most recent filings (of 824)
Every SEC filing, newest first, with what it is. Below, each type with its own explanation.
- Oct 13, 268-K ↗Current report · Took on a new financial obligation new
- Sep 29, 26Form 144 ↗Notice of proposed sale
- Sep 28, 26Form 4 ↗Insider transaction
Notice of proposed sale · 2 Form 144 filingsshow all 2hide
- Sep 25, 26Form 144 ↗Notice of proposed sale
- Sep 24, 26Form 144 ↗Notice of proposed sale
- Sep 22, 26Form 144 ↗Notice of proposed sale
- Sep 18, 26Form 144 ↗Notice of proposed sale
Notice of proposed sale · 5 Form 144 filingsshow all 5hide
- Sep 15, 26Form 144 ↗Notice of proposed sale
- Sep 15, 26Form 144 ↗Notice of proposed sale
- Sep 15, 26Form 144 ↗Notice of proposed sale
- Sep 15, 26Form 144 ↗Notice of proposed sale
- Sep 15, 26Form 144 ↗Notice of proposed sale
- Sep 15, 26Form 4 ↗Insider transaction
- Sep 15, 26Form 144 ↗Notice of proposed sale
824 filings on record, the oldest from Oct 16, 19.
Listing the 25 most recent filings of the 824 on record.
1411
- Oct 13, 26Took on a new financial obligation+1 more in the same filing8-K 2.03 ↗
- Sep 1, 26Took on a new financial obligation+1 more in the same filing8-K 2.03 ↗
- Jun 22, 26A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Apr 17, 26Took on a new financial obligation+3 more in the same filing8-K 2.03 ↗
- Jun 24, 25Entered a material agreement+3 more in the same filing8-K 1.01 ↗
- Jun 18, 25A senior executive left or was appointed8-K 5.02 ↗
- Aug 7, 24A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Nov 9, 23Completed an acquisition or disposal+4 more in the same filing8-K 2.01 ↗
- Sep 5, 23A senior executive left or was appointed8-K 5.02 ↗
- Aug 1, 23Entered a material agreement+3 more in the same filing8-K 1.01 ↗
- Dec 7, 22A material agreement was terminated8-K 1.02 ↗
3 senior executive changes2022show all 3hide
- Sep 1, 22A senior executive left or was appointed8-K 5.02 ↗
- Jul 13, 22A senior executive left or was appointed8-K 5.02 ↗
- Jun 10, 22A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
5 older filings not shown
Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.
Schedule 13G: short-form filing
The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.
- Dapice Joshua J.7.5%Dec 31, 25SCHEDULE 13G/A ↗31 co-filers on this document — the figure is the largest single stake, not their sum.
- Farallon Capital Management, L.L.C.6.4%Jun 30, 26SCHEDULE 13G/A ↗29 co-filers on this document — the figure is the largest single stake, not their sum.
- BlackRock, Inc.5.7%Jun 30, 26SCHEDULE 13G ↗1 earlier filing
- Baker Bros. Advisors LP5.3%Jun 30, 26SCHEDULE 13G ↗4 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
- JANUS HENDERSON GROUP Ltd.5.1%Jun 30, 26SCHEDULE 13G ↗3 earlier filings
show 2 more holdershide
- FMR LLC5.0%Sep 30, 25SCHEDULE 13G ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
- Wellington Management Group LLP3.6%Dec 31, 25SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.
Sale intention announced
On Sep 29, ALAN SANDLER filed notice of intent to sell up to $1.3M. It is filed under a scheduled plan (10b5-1), arranged in advance.
A notice is not a sale: it may not go ahead, may happen in part, or at a different price.
After the notice, they sold $1.3M across 5 trades on Sep 29, per their Form 4. That is 100% of the shares announced so far, and the window is still open.
View notice (Form 144) ↗+9 more recent notices · 9 with a later sale
- Sep 29, 26Sell$442KAlan B. SandlerChief Development Officer↗
- Sep 29, 26Sell$325KAlan B. SandlerChief Development Officer↗
- Sep 29, 26Sell$203KAlan B. SandlerChief Development Officer↗
- Sep 29, 26Sell$244KAlan B. SandlerChief Development Officer↗
- Sep 29, 26Sell$62KAlan B. SandlerChief Development Officer↗
- Sep 25, 26Sell$626KAnthony ManciniSee Remarks↗
- Sep 25, 26Sell$159KJeff CisliniSVP & General Counsel↗
- Sep 24, 26Sell$117KAnthony ManciniSee Remarks↗
- Sep 22, 26Sell$175KELIZABETH M ANDERSON↗
- Sep 22, 26Sell$960KELIZABETH M ANDERSON↗
- Sep 22, 26Sell$512KELIZABETH M ANDERSON↗
- Sep 22, 26Sell$292KELIZABETH M ANDERSON↗
There are 23 more transactions in this stretch.
Stock compensation, tax and giftsshow the 5 other transactionshide
Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.
The full record holds 467 transactions and goes back to Feb 22, 23.
Its sector and its market
Revolution Medicines Inc. among Health Care companies
The profile shows what is on record. Context and Radar place the company among those of its sector and region.
Browse its neighbours
Other Health Care companies
With an account you also get
- The four engines — growth, trend, risk and context — each with its word and its score.
- The risk band and the sector phase.
- The company's fundamentals and accounts.
- Watchlist: your list of companies, with the «since you follow it» figure.
The research continues
The profile tells the story. The market sets the scene.
From Revolution Medicines Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.
See what deserves a closer look
Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.
See how Radar works →Keep the why
Follow Revolution Medicines Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.
See an example review →
Coverage
What sits behind this page.
Where each figure comes from and how far it reaches.
- Prices
- End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
- Series quality
- Series with incidents in the period; the chart shows what could be kept.
- SEC records
- 824 documents on file, from Oct 16, 2019 to Oct 13, 2026.
- Company description
- No description available.
- This page
- Generated on Oct 19, 2026; refreshed through the day.
Start at your own pace
Explore first. Go deeper with access.
Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.
Compare plans →- No account
This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.
- Pro
What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.
- Pro+
Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.
Are the prices real time?
No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.
Which SEC documents appear here?
Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.
Why does a European company show no SEC records?
It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.
Before forming a view on a company,
read what is on record.
One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.